NCT02406690View on ClinicalTrials.gov

Endometrial Receptivity Profile in Patients With Endometrial Proliferation Defects

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

September 17, 2015

Study Completion Date

September 17, 2015

Conditions
Endometrial Dysfunction
Interventions
OTHER

Estradiol Valerate, Progesterone in Oil, Leuprolide

Patients will undergo a Leuprolide endometrial preparatory cycle using estradiol valerate, progesterone in oil and once completed will have a uterine aspiration and biopsy performed.

Trial Locations (1)

07920

Reproductive Medicine Associates of New Jersey, Basking Ridge

All Listed Sponsors
lead

Reproductive Medicine Associates of New Jersey

OTHER

NCT02406690 - Endometrial Receptivity Profile in Patients With Endometrial Proliferation Defects | Biotech Hunter | Biotech Hunter